SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer.

Pengcheng Yu Weiyang He Yanqiang Zhang Xiang-Dong Cheng Yue Wu Yi Wang Zhehan Bao Yuhang Xia Ruolan Zhang Mengxuan Cao Li Yuan Xiang-Dong Cheng Zhiyuan Xu

Published in: Journal of oncology (2022)

SFRP4 is an oncogenic driver that can predict patient survival time in gastric cancer, as well as an important immune-related factor. SFRP4 may be important for guiding immunotherapy in gastric cancer patients.

Keyphrases

case report
transcription factor
free survival
drug induced